J Bone Metab.  2013 Nov;20(2):111-114. 10.11005/jbm.2013.20.2.111.

A Case of Teriparatide on Pregnancy-Induced Osteoporosis

• Lee SH
• Hong MK
• Park SW
• Park HM
• Kim J
• Ahn J

• KMID: 2286303
• DOI: http://doi.org/10.11005/jbm.2013.20.2.111

Abstract

Pregnancy-induced osteoporosis is a rare disorder characterized by fragility fracture and low bone mineral density (BMD) during or shortly after pregnancy, and its etiology is still unclear. We experienced a case of a 39-year-old woman who suffered from lumbago 3 months after delivery. Biochemical evidence of increased bone resorption is observed without secondary causes of osteoporosis. Radiologic examination showed multiple compression fractures on her lumbar vertebrae. We report a case of patient with pregnancy-induced osteoporosis improved her clinical symptom, BMD and bone turnover marker after teriparatide therapy.

Keyword

Osteoporosis; Pregnancy; Teriparatide

MeSH Terms

Adult
Bone Density
Bone Resorption
Female
Fractures, Compression
Humans
Low Back Pain
Lumbar Vertebrae
Osteoporosis*
Pregnancy
Teriparatide*
Teriparatide

Figure

• 

  Fig. 1 Supine (A) and lateral (B) view of lumbar spine show compression fractures at L1-L5.

• 

  Fig. 2 Magnetic resonance imaging (T1 and T2 weighted images) of lumbar spine. (A) T1 weighted images show ill-defined hypointense lesion in L1-L5. (B) T2 weighted images show high signal intensity in the lesion.

• 

  Fig. 3 Bone scan shows hot uptake on 6-8th left ribs and L1-L5 vertebrae.

Reference

1. O'Sullivan SM, Grey AB, Singh R, et al. Bisphosphonates in pregnancy and lactation-associated osteoporosis. Osteoporos Int. 2006; 17:1008–1012.

2. Nordin BE, Roper A. Post-pregnancy osteoporosis; a syndrome? Lancet. 1955; 268:431–434.

3. Sowers MF, Hollis BW, Shapiro B, et al. Elevated parathyroid hormone-related peptide associated with lactation and bone density loss. JAMA. 1996; 276:549–554.

4. Black AJ, Topping J, Durham B, et al. A detailed assessment of alterations in bone turnover, calcium homeostasis, and bone density in normal pregnancy. J Bone Miner Res. 2000; 15:557–563.

5. Dunne F, Walters B, Marshall T, et al. Pregnancy associated osteoporosis. Clin Endocrinol (Oxf). 1993; 39:487–490.

6. Ofluoglu O, Ofluoglu D. A case report: pregnancy-induced severe osteoporosis with eight vertebral fractures. Rheumatol Int. 2008; 29:197–201.

7. Ghannam NN, Hammami MM, Bakheet SM, et al. Bone mineral density of the spine and femur in healthy Saudi females: relation to vitamin D status, pregnancy, and lactation. Calcif Tissue Int. 1999; 65:23–28.

8. Phillips AJ, Ostlere SJ, Smith R. Pregnancy-associated osteoporosis: does the skeleton recover? Osteoporos Int. 2000; 11:449–454.

9. Di Gregorio S, Danilowicz K, Rubin Z, et al. Osteoporosis with vertebral fractures associated with pregnancy and lactation. Nutrition. 2000; 16:1052–1055.

10. Hellmeyer L, Boekhoff J, Hadji P. Treatment with teriparatide in a patient with pregnancy-associated osteoporosis. Gynecol Endocrinol. 2010; 26:725–728.

11. Hassen-Zrour S, Korbâa W, Béjia I, et al. Maternal and fetal outcome after long-term bisphosphonate exposure before conception. Osteoporos Int. 2010; 21:709–710.

12. Munns CF, Rauch F, Ward L, et al. Maternal and fetal outcome after long-term pamidronate treatment before conception: a report of two cases. J Bone Miner Res. 2004; 19:1742–1745.

13. Losada I, Sartori L, Di Gianantonio E, et al. Bisphosphonates in patients with autoimmune rheumatic diseases: can they be used in women of childbearing age? Autoimmun Rev. 2010; 9:547–552.

14. Choe EY, Song JE, Park KH, et al. Effect of teriparatide on pregnancy and lactation-associated osteoporosis with multiple vertebral fractures. J Bone Miner Metab. 2012; 30:596–601.